Richard B. Pollard
Director Técnico/Científico/I+D en Genetic Immunity, Inc. .
Perfil
Richard B.
Pollard has been Chief Medical Officer of Genetic Immunity LLC since December, 2007.
He is a Professor of Internal Medicine an Microbiology and Chief of the Division of Infectious Diseases for Davis Medical School.
Dr. Pollard currently serves as the Principal Investigator of the Immunology Specialty Laboratory, Chairman of the ACTG Laboratory Evaluation Subcommittee, and Principal Investigator of the California Research Center for the Biology of HIV in Minorities.
He was Director of Research for US Navy.
Dr. Pollard was an Assistant Professor of Internal Medicine at the University of Texas at Galveston and appointed as a Professor of Internal Medicine, Pathology, and Microbiology in 1989.
He received his undergraduate degree from the University of Maryland in College Park and Baltimore.
Cargos activos de Richard B. Pollard
| Empresas | Cargo | Inicio |
|---|---|---|
Genetic Immunity, Inc.
 Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Director Técnico/Científico/I+D | 01/12/2007 |
Antiguos cargos conocidos de Richard B. Pollard.
| Empresas | Cargo | Fin |
|---|---|---|
| The University of Texas at Austin | Corporate Officer/Principal | - |
Formación de Richard B. Pollard.
| University of Maryland | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Genetic Immunity, Inc.
Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Health Technology |
- Bolsa de valores
- Insiders
- Richard B. Pollard
